Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
The pharmaceutical industry is constantly on the lookout for novel compounds that can serve as building blocks for next-generation therapies. YDL223C, also known as HBT1, has emerged as a significant pharmaceutical intermediate with considerable potential, particularly in the realm of neuroscience. Identified by CAS number 489408-02-8, this compound is valued for its role as a potent AMPA-R potentiator.
YDL223C's primary mechanism involves enhancing the activity of AMPA-R, a glutamate receptor crucial for excitatory neurotransmission. This enhancement is linked to improved synaptic plasticity, a process fundamental for learning and memory. Moreover, YDL223C has been shown to stimulate the production of Brain-Derived Neurotrophic Factor (BDNF), a protein that plays a critical role in neuronal survival, growth, and differentiation. This dual action makes it a highly sought-after compound for research into brain health and cognitive function.
The therapeutic implications of YDL223C are vast, especially concerning neurodegenerative diseases. Conditions such as Alzheimer's disease, characterized by cognitive decline and neuronal damage, could potentially benefit from compounds that support neuronal health and plasticity. YDL223C's ability to boost BDNF and modulate AMPA-R activity positions it as a promising candidate for drug development aimed at mitigating these conditions. Researchers can investigate its use by purchasing YDL223C for their studies.
Beyond neurodegenerative disorders, YDL223C is also being explored for its potential impact on conditions like schizophrenia and autism, where neural circuit function is often impaired. The precise modulation of neurotransmitter systems that YDL223C offers could provide novel therapeutic strategies for these complex disorders.
NINGBO INNO PHARMCHEM CO.,LTD. is a key supplier of YDL223C, ensuring that the pharmaceutical research community has access to this vital intermediate. The availability of high-quality YDL223C from NINGBO INNO PHARMCHEM CO.,LTD. enables scientists to conduct thorough investigations into its therapeutic applications, contributing to advancements in the treatment of neurological and cognitive disorders. Sourcing YDL223C is a crucial step for companies involved in pharmaceutical innovation.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
